Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 3/20 | 0.48 |
| ▸ | HMGCR | P04035 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | NEK2 | P51955 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7140544 | 0.90 | NR1I2 (0.37) | NR1I2HMGCRPOLBKMT2AMEN1 | |
| SCHEMBL7083291 | 0.87 | NR1I2 (0.35) | NR1I2HMGCRMAPTHSD11B1HSD17B2 | |
| SCHEMBL7086714 | 0.81 | HMGCR (0.42) | HMGCRHSD11B1HSD17B2 | |
| SCHEMBL9358626 | 0.78 | BCL2L1 (0.34) | HSD11B1HSD17B2 | |
| SCHEMBL7080881 | 0.76 | HMGCR (0.62) | NR1I2HMGCRKMT2ALMNAMEN1 | |
| SCHEMBL7138482 | 0.75 | NR1I2 (0.57) | NR1I2HMGCRPOLBKMT2ALMNA | |
| SCHEMBL7080263 | 0.68 | HMGCR (0.42) | HMGCRPOLBLMNAL3MBTL1HSD11B1 | |
| SCHEMBL5664806 | 0.67 | NR1I2 (0.73) | NR1I2HMGCRKMT2ALMNAMEN1 | |
| SCHEMBL704959 | 0.67 | BCL2L1 (0.41) | KMT2AMEN1L3MBTL1HSD11B1HSD17B2 | |
| SCHEMBL9358332 | 0.67 | HMGCR (0.50) | NR1I2HMGCRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1326618-A2 | USE OF ARYL-SUBSTITUTED 1,1-DIPHOSPHONATES FOR THE TREATMENT OF BONE DISEASES | Ilex Oncology Research S.A. (CH) | 2003-07-16 | — | — | EP | claimed |
| WO-2002011704-A2 | USE OF ARYL-SUBSTITUTED 1,1-DIPHOSPHONATES FOR THE TREATMENT OF BONE DISEASES | SYMPHAR S.A. (CH) | 2002-02-14 | — | — | WO | claimed |
| EP-0418064-B1 | Naphthalene and tetrahydronaphthalene gem-diphosphonate derivatives | SYMPHAR SA (CH) | 1994-12-14 | — | — | EP | disclosed |
| US-5204336-A | Anticholestrol agents | SYMPHAR S.A. (CH) | 1993-04-20 | — | — | US | disclosed |
| EP-0418064-A2 | Naphthalene and tetrahydronaphthalene gem-diphosphonate derivatives | SYMPHAR S.A. (CH) | 1991-03-20 | — | — | EP | disclosed |